Breaking New Ground with Incretin Therapy in Diabetes
- PMID: 34170646
- DOI: 10.1056/NEJMe2109957
Breaking New Ground with Incretin Therapy in Diabetes
Comment on
-
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.N Engl J Med. 2021 Aug 5;385(6):503-515. doi: 10.1056/NEJMoa2107519. Epub 2021 Jun 25. N Engl J Med. 2021. PMID: 34170647 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical